Today: 20 May 2026
Klaviyo stock drops nearly 10% as 2026 opens — what KVYO investors watch next
4 January 2026
1 min read

Klaviyo stock drops nearly 10% as 2026 opens — what KVYO investors watch next

NEW YORK, Jan 3, 2026, 19:55 ET — Market closed

  • Klaviyo shares closed down 9.7% on Friday, underperforming several software peers.
  • U.S. Treasury yields rose as markets started 2026, a backdrop that often pressures high-growth software valuations.
  • The company’s next earnings report is estimated for Feb. 18.

Shares of Klaviyo (KVYO) closed down 9.7% on Friday at $29.32, marking a sharp slide on the first trading day of 2026.

The move matters now because investors began the new year with a fresh rate backdrop: U.S. Treasury yields climbed, and growth stocks lagged as traders recalibrated expectations for Federal Reserve policy and upcoming data.

Klaviyo’s drop also puts attention back on what the company says about 2026 demand and margins when it next reports results, with the earnings date currently estimated for Feb. 18.

U.S. stocks finished mixed on Friday, with the Dow and S&P 500 higher while the Nasdaq ended slightly lower, weighed by megacap tech. The benchmark 10-year yield rose to about 4.19%.

High-growth software names broadly weakened, though Klaviyo’s decline was steeper than several larger peers: HubSpot fell about 4.7% and Salesforce slid about 4.3% on the day, while Shopify dropped about 2.3%.

Trading conditions were also thin around the holiday, which can amplify intraday swings. “People not engaged normally,” said Jed Ellerbroek, a portfolio manager at Argent Capital. Reuters

Klaviyo traded between $29.15 and $32.46 on Friday and ended the session with about 4.93 million shares changing hands.

On the analyst side, Zacks Investment Research currently assigns Klaviyo a Rank #1 (“Strong Buy”), citing upward earnings estimate revisions in its model. Zacks Advisor Tools

The company sells a software platform that helps brands send and measure marketing messages across email, SMS text and push notifications.

Investors have also been watching leadership changes: Chano Fernández joined co-founder Andrew Bialecki as co-chief executive officer effective Jan. 1, following a board appointment disclosed in an SEC filing.

Before Monday’s open, attention will turn to the next wave of U.S. economic releases that traders see as key for the Fed’s path, after disruptions left some indicators delayed.

The next company waypoint is earnings, with Feb. 18 the current estimate from market calendars and Zacks data. Traders will be looking for any change in growth expectations and signs of progress on profitability.

Technically, investors will watch whether KVYO holds near Friday’s low around $29 and whether it can reclaim the low-$30s, after a session that spanned more than $3 a share. The stock’s 52-week range sits roughly between $23.44 and $49.55, according to Zacks data.

Stock Market Today

  • Tesla Q1 2026 Earnings Beat; Stock Faces Mixed Outlook for 2030
    May 20, 2026, 10:24 AM EDT. Tesla (TSLA) reported Q1 2026 earnings per share (EPS) of $0.41, exceeding the $0.36 consensus, with automotive gross margin rising to 21.1% from 16.2%. Operating income increased 135.8% year-on-year (YoY), and services plus Full Self-Driving (FSD) revenue jumped 42% to $3.75 billion, with 1.28 million active FSD subscriptions up 51%. Despite strong fundamentals, Tesla shares fell 8.83% year-to-date to $409.99 amid skepticism about AI monetization and scaling autonomy. Wall Street's average target is about $412, while a proprietary model estimates a base case price of $510 by 2030, with a bull case of $645. Achieving $650 requires significant price-to-earnings multiple expansion or sharp EPS growth from AI ventures, amid challenges like increased operating expenses and production constraints.

Latest articles

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

20 May 2026
POET Technologies shares rose 11% to $14.55 in early Nasdaq trading Wednesday after closing a US$400 million direct offering of 19 million shares and warrants. The rebound followed an 8% drop Tuesday on dilution concerns. The company reported Q1 revenue of $503,389 and a net loss of $12.3 million. A recent $50 million order from Lumilens could scale to $500 million over five years if production ramps up.
Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

20 May 2026
Nokia shares rose 3.37% in Helsinki trading Wednesday after the FCC conditionally approved its Beacons and ONT devices, exempting them from U.S. Covered List restrictions. Nokia also transferred 975,289 treasury shares to equity plan participants. Dell’Oro Group forecasts the optical transport equipment market will grow 16% in 2026, driven by AI data centers.
Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

20 May 2026
Biogen completed its acquisition of Apellis Pharmaceuticals, removing APLS shares from Nasdaq and paying investors $41 per share plus a contingent value right tied to Syfovre sales. Apellis shareholders tendered 82.4% of outstanding stock before the offer expired May 13. Biogen shares rose 0.9% to $192.34 Wednesday. The CVR could pay up to $4 if Syfovre meets future sales targets.
Bloom Energy stock jumps 14% to start 2026 as fuel-cell names rebound — what investors watch next
Previous Story

Bloom Energy stock jumps 14% to start 2026 as fuel-cell names rebound — what investors watch next

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus
Next Story

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Go toTop